Sigachi Industries Limited submitted a revised disclosure to correct a typographical error in its unaudited financial results for the quarter ended September 30, 2026. The original submission dated October 31, 2026, contained an error in the limited review report where the reporting period was incorrectly mentioned as June 30, 2026 (30.06.2026) instead of September 30, 2026 (30.09.2026).
The company has submitted a revised limited review report with the correct reporting period of September 30, 2026. All other information submitted in the original Board Meeting Outcome Letter dated October 31, 2026, remains unchanged, including all financial figures and results.
The limited review report was prepared by Yelamanchi & Associates (Firm Registration No. 000041S), Chartered Accountants, and was signed by Partner G Jayahth Grinivas (Membership No. 251026). The report confirms that the unaudited consolidated financial results have been prepared in accordance with Indian Accounting Standard 34 (Ind AS 34) and SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
The consolidated results include three subsidiary entities:
- Sigachi US INC
- Sigachi MENA FZCO
- Trimax Bio Sciences Private Limited
For the half year ended September 30, 2026, these subsidiaries collectively reported:
- Total revenue: ₹83,70,77,576 (₹83.71 crore)
- Total net profit: ₹1,59,74,250 (₹1.60 crore)
The limited review report emphasizes that the review provides substantially less assurance than a full audit and does not express an audit opinion. The conclusion states that nothing has come to the auditor's attention that causes them to believe that the statement contains any material misstatement.
The submission was made by Vivek Kumar, Company Secretary & Compliance Officer of Sigachi Industries Limited, on November 5, 2026, and is addressed to both BSE Limited and National Stock Exchange of India Limited.